This HTML5 document contains 14 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n8http://commons.wikimedia.org/wiki/Special:FilePath/Nicholas_Lydon.jpg?width=
dchttp://purl.org/dc/elements/1.1/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n7http://commons.wikimedia.org/wiki/Special:FilePath/Nicholas_Lydon.
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpediahttp://dbpedia.org/resource/
Subject Item
dbpedia:Nicholas_Lydon
rdfs:comment
Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009 he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition.
foaf:name
Nicholas Lydon Lydon, Nicholas
foaf:depiction
n7:jpg
dc:description
British biochemist
dbpedia-owl:almaMater
dbpedia:University_of_Leeds dbpedia:University_of_Dundee
dbpedia-owl:award
dbpedia:Lasker_Award dbpedia:Royal_Society dbpedia:Japan_Prize
dbpedia-owl:birthDate
1957-02-27Z
dbpedia-owl:birthYear
1957-01-01Z
dbpedia-owl:knownFor
dbpedia:Imatinib
dbpedia-owl:thumbnail
n8:300